Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenon Medical (TNON) Liabilities and Shareholders Equity (2021 - 2025)

Historic Liabilities and Shareholders Equity for Tenon Medical (TNON) over the last 5 years, with Q3 2025 value amounting to $10.4 million.

  • Tenon Medical's Liabilities and Shareholders Equity fell 2050.0% to $10.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $44.7 million, marking a year-over-year increase of 3384.32%. This contributed to the annual value of $9.8 million for FY2024, which is 5513.0% up from last year.
  • According to the latest figures from Q3 2025, Tenon Medical's Liabilities and Shareholders Equity is $10.4 million, which was down 2050.0% from $11.1 million recorded in Q2 2025.
  • In the past 5 years, Tenon Medical's Liabilities and Shareholders Equity ranged from a high of $18.1 million in Q2 2022 and a low of $6.0 million during Q2 2024
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $9.8 million (2023), whereas its average is $10.2 million.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first crashed by 5100.76% in 2023, then soared by 8504.83% in 2025.
  • Over the past 5 years, Tenon Medical's Liabilities and Shareholders Equity (Quarter) stood at $9.3 million in 2021, then grew by 19.6% to $11.1 million in 2022, then tumbled by 42.78% to $6.3 million in 2023, then soared by 55.13% to $9.8 million in 2024, then grew by 5.31% to $10.4 million in 2025.
  • Its Liabilities and Shareholders Equity was $10.4 million in Q3 2025, compared to $11.1 million in Q2 2025 and $13.4 million in Q1 2025.